Duracrin, LLC

SEC filing

Biotechnology · New Haven, CT

Form D on EDGAR

Amount raised$1Msold at filing

Total offering$1M

Investors in the raise2count reported to the SEC

FiledFeb 25, 2026first sale Feb 3, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Craig CrewsDirector

Sean CassidyExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.